(Q44799887)

6 December 2017

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation (English)

1 reference

6 December 2017

0 references

1 reference

cytomegaloviral disease

1 reference

1 reference

10

E D Thomas

1 reference

6 December 2017

J D Meyers

1

1 reference

6 December 2017

E C Reed

2

1 reference

6 December 2017

D H Shepp

3

1 reference

6 December 2017

M Thornquist

4

1 reference

6 December 2017

P S Dandliker

5

1 reference

6 December 2017

C A Vicary

6

1 reference

6 December 2017

N Flournoy

7

1 reference

6 December 2017

L E Kirk

8

1 reference

6 December 2017

J H Kersey

9

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 January 1988

1 reference

The New England Journal of Medicine

6 December 2017

1 reference

6 December 2017

318

1 reference

6 December 2017

2

1 reference

6 December 2017

70-75

1 reference

Intravenous Lymphoblastoid Interferon and Acyclovir for Treatment of Cytomegaloviral Pneumonia

6 December 2017

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Prophylaxis: a strategy to minimise antiviral resistance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

The in vitro activity of Acyclovir and related compounds against cytomegalovirus infections

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Treatment of cytomegalovirus pneumonia with high-dose acyclovir

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Nonparametric Estimation from Incomplete Observations

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Cytomegalovirus Infection and Specific Cell-Mediated Immunity after Marrow Transplant

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Risk factors for cytomegalovirus infection after human marrow transplantation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Treatment of Cytomegaloviral Pneumonia with High-Dose Acyclovir and Human Leukocyte Interferon

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Natural cytotoxic activity against cytomegalovirus-infected target cells following marrow transplantation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Toxicity and Efficacy of Human Leukocyte Interferon for Treatment of Cytomegalovirus Pneumonia after Marrow Transplantation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Association of Herpesvirus Infections with T-Lymphocyte-Subset Alterations, Glomerulopathy, and Opportunistic Infections after Renal Transplantation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Bone-marrow transplantation (first of two parts).

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Treatment of cytomegalovirus pneumonia with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine and high-dose corticosteroids

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Inhibition of cellular alpha and virally induced deoxyribonucleic acid polymerases by the triphosphate of acyclovir

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJM198801143180202

Identifiers

DOI

10.1056/NEJM198801143180202

1 reference

6 December 2017

1 reference